Validation of a biomarker‐based mortality score for cardiogenic shock patients: Comparison with a clinical risk score

Validation of a biomarker‐based mortality score for cardiogenic shock patients: Comparison with a clinical risk score

Abstract Aims Cardiogenic shock (CS) is the deadliest manifestation of acute heart failure, with persistently high mortality rates and a lack of recent therapeutic breakthroughs. Accurate risk prediction is crucial in clinical decision‐making and the design of future clinical trials. We aimed to val...

Full description

Saved in:
Bibliographic Details
Main Authors: Elina Hynninen, Heli Tolppanen, Mercedes Rivas‐Lasarte, Tuukka Tarvasmäki, Veli‐Pekka Harjola, Benjamin Deniau, Mari Hongisto, Ewa A. Jankowska, Raija Jurkko, Toni Jäntti, Anu Kataja, Alexandre Mebazaa, Tuija Sabell, Alessandro Sionis, Johan Lassus
Format: Article
Language:English
Published: Wiley 2025-06-01
Series:ESC Heart Failure
Subjects:
Cardiogenic shock
Biomarkers
Mortality prediction
Risk score
Online Access:https://doi.org/10.1002/ehf2.15234
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/ehf2.15234

Similar Items